中國透雲(01332.HK)與承包商訂手孔及加熱管協議 發展萊茵衣藻及微藻業務
中國透雲(01332.HK)公布,附屬公司山西透雲生物科技與河北承包商訂立第三份手孔及加熱管協議,就於山西省長治市潞城區店上鎮常莊村潞城經濟技術開發區生產萊茵衣藻、微藻及相關產品採購,及安裝8個手孔及2條加熱管,代價11.52萬元人民幣。
公司指,建設發酵及相關設施乃集團多元化發展萊茵衣藻、微藻及相關產品業務的第一步,預期公司將於今年開始生產萊茵衣藻、微藻及相關產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.